Filing Details
- Accession Number:
- 0001138723-18-000114
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-12-06 19:57:19
- Reporting Period:
- 2018-11-30
- Accepted Time:
- 2018-12-06 19:57:19
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1138723 | Accuray Inc | ARAY | Surgical & Medical Instruments & Apparatus (3841) | 770268932 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1704812 | J Andrew Kirkpatrick | 1310 Chesapeake Terrace Sunnyvale CA 94089 | Svp, Chief Operations Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2018-12-03 | 1,784 | $4.11 | 238,136 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Non-Qualified Stock Option (right to buy) | Acquisiton | 2018-11-30 | 374,000 | $0.00 | 374,000 | $4.10 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
374,000 | 2028-11-30 | No | 4 | A | Direct |
Footnotes
- Shares were automatically sold in accordance with Accuray policy for all restricted stock unit (RSU) releases in order to cover tax obligations upon RSU release and is consistent with Accuray practices for all RSU releases of employees located in the United States.
- Includes 2,500 shares acquired on Nov 30, 2018 under the Accuray Employee Stock Purchase Plan in transactions that were exempt under Rule 16b-3(c).
- The options are exercisable as they vest. A total of 25% of the entire number of shares subject to this stock option becomes vested and fully exercisable on the first anniversary of the vesting commencement date and the remaining shares subject to this stock option vest and become exercisable in equal monthly installments, ratably over the following 36 months.